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Abstract: The paraventricular nucleus (PVN) of the hypothalamus has been described as the "autonomic master controller". 
It co-ordinates critical physiological responses through control of the hypothalamic-pituitary-adrenal (HPA)-axis, and by 
modulation of the sympathetic and parasympathetic branches of the central nervous system. The PVN comprises several 
anatomical subdivisions, including the parvocellular/ mediocellular subdivision, which contains neurones projecting to the 
medulla and spinal cord. Consensus indicates that output from spinally-projecting sympathetic pre-autonomic neurones 
(SPANs) increases blood pressure and heart rate, and dysfunction of these neurones has been directly linked to elevated 
sympathetic activity during heart failure. The influence of spinally-projecting SPANs on cardiovascular function high-
lights their potential as targets for future therapeutic drug development. Recent studies have demonstrated pharmacologi-
cal control of these spinally-projecting SPANs with glutamate, GABA, nitric oxide, neuroactive steroids and a number of 
neuropeptides (including angiotensin, substance P, and corticotrophin-releasing factor). The underlying mechanism of 
control appears to be a state of tonic inhibition by GABA, which is then strengthened or relieved by the action of other 
modulators. The physiological function of spinally-projecting SPANs has been subject to some debate, and they may be 
involved in physiological stress responses, blood volume regulation, glucose regulation, thermoregulation and/or circadian 
rhythms. This review describes the pharmacology of PVN spinally-projecting SPANs and discusses their likely roles in 
cardiovascular control.  
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parvocellular mediocellular, neuropeptides, oxytocin, substance P, tachykinin, vasopressin, angiotensin, pharmacology.  
1. INTRODUCTION  
  The paraventricular nucleus (PVN) of the hypothalamus 
is a critical regulator of numerous endocrine and autonomic 
functions [1-5]; Loewy [6] referred to it as being the “auto-
nomic master controller”. Many of these autonomic func-
tions are served by spinally-projecting neurones (Fig. 1), a 
number of which have been shown to be involved in cardio-
vascular regulation [7]. These and other spinally-projecting 
sympathetic pre-autonomic neurones (SPANs)  in the PVN 
are therefore attractive targets for pharmacological manipu-
lation of both the cardiovascular system and potentially, 
other autonomic systems. 
  The cardiovascular system is subject to numerous levels 
of control. Although the basic functions of the heart and 
blood vessels are controlled locally, the whole system is cen-
trally regulated by the brain [8, 9]. Part of the central regula-
tion comes from the medulla, which allows rapid adaptation 
to changing homeostatic challenges. Anticipatory regulation, 
however, allows for an increase in cardiac output just prior to 
increased systemic oxygen demand. This was termed the 
“preparatory reflex” [10] and appears to be the highest level 
of cardiovascular control. The process is largely attributed to 
an increase in sympathetic activity, and was first identified  
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by Walter Cannon [11]. This reflex is now more commonly 
referred to as the “fight-or-flight” response, the “stress re-
sponse”, or the “defence reaction”. Inappropriate activation 
of this system may lead to hypertension and could account 
for the increased cardiac death resulting from stressors such 
as exercise [12], anger [13] or emotional shock [14]. Fur-
thermore, some aspects of this pathway appear to be acti-
vated in chronic heart failure [15]. Forebrain regions in-
volved in cardiovascular regulation were discovered early in 
the 20
th century by stimulation or ablation of specific areas 
[16, 17]. Later, several areas of the hypothalamus (Fig. 2)
were shown to be of particular importance [e.g., 18, 19, 20]. 
These include areas we now know as the PVN and the dor-
somedial hypothalamus (DMH), although both were poorly 
defined at the time. The PVN comprises approximately 
21,500 neurones, approximately three quarters of which 
make up the parvocellular subdivision [21], which includes 
both spinally-projecting SPANs and hypothalamic-pituitary-
adrenal (HPA) axis control neurones [3, 6, 22].  
  Estimates suggest that up to 2000 neurones project di-
rectly from the PVN to the intermediolateralis (IML) of the 
spinal cord [23-25], and terminate close to sympathetic pre-
ganglionic neurones [26, 27] and are, in this review, collec-
tively termed spinally-projecting sympathetic pre-autonomic 
neurones (spinally-projecting SPANs). SPAN cell bodies are 
found most densely in a region of the PVN termed the par-
vocellular subnucleus, particularly in a subdivision referred 
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  Spinally-projecting SPANs are strongly implicated in 
cardiovascular control [7, 28-30], but their primary role is 
unknown (Fig. 3). Several hypotheses have been proposed 
such as; circadian regulation of blood pressure [31], blood-
volume regulation [24, 25] and the cardiovascular response 
to psychological stress [32]. Furthermore, elevated sympa-
thetic activity is associated with congestive heart failure [15, 
33, 34], and may also be associated with diminished GABA 
sensitivity of PVN neurones [15, 35, 36]. This review will 
discuss the neuropharmacology and function of spinally-
projecting SPANs of the PVN. In the majority of cases these 
experiments have focussed on control of the rat cardiovascu-
lar system, although recently, study of spinally-projecting 
SPANs has broadened to entirely new systems such as   
glucose regulation, thermoregulation and penile erection. 
Fig. (1). Spinally-projecting sympathetic pre-autonomic neurones of the paraventricular nucleus of the hypothalamus (PVN). The
PVN consists of several sub-populations of neurones some of which project to the spinal cord. There are likely to be each combination indi-
cated in the Venn diagram. This review focuses on the shaded area; spinally-projecting sympathetic pre-autonomic neurones (spinally-
projecting SPANs) of the PVN. Many of these target the cardiovascular system (CVS). 
Fig. (2). Central cardiovascular control in the rat. The cardiovascular system is largely controlled by areas of the brainstem; however, 
there is also strong evidence that centres in the forebrain, including the PVN, exert “top-level” control via both medulla-projecting and spi-
nally-projecting SPANs. Afferents from carotid baroreceptors ascend via cranial nerve IX (the glossopharangeal nerve), while afferents from 
the aortic bodies ascend via cranial nerve X (the vagus nerve). These afferents are processed by the nucleus of the solitary tract (NTS). Para-
sympathetic drive emanates from the nucleus ambiguus, whilst sympathetic drive emanates from a number of locations, in particular the 
rostroventrolateral medulla. The role of the medulla in cardiovascular control is reviewed by [9]. 
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2. ELECTROPHYSIOLOGY OF SPINALLY-PROJECTING 
SPANS  
  A number of in vitro studies have investigated the elec-
trophysiological properties of PVN neurones [37-40]. They 
show that parvocellular neurones (termed “PVN type II” 
neurones) express a slowly inactivating delayed rectifier 
potassium conductance. Conversely, the neurosecretory 
magnocellular neurones of the PVN (termed “PVN type I” 
neurones) appear to express a rapidly inactivating (A-type) 
potassium conductance. Fewer studies have been conducted 
on identified spinally-projecting SPANs; medulla-projecting 
neurones show strong inward rectification and “A-type” po-
tassium conductance [41, 42] and spinally-projecting SPANs 
show a slowly inactivating potassium conductance [43]. 
More recent studies have also identified ATP dependent   
potassium channels [44, 45], which may serve to couple   
glucose levels to sympathetic activity. Pharmacological 
characterisation of the potassium channels involved is possi-
ble using potassium channels inhibitors [46-53], although 
confirmation requires immunohistochemical or RT-PCR 
approaches since most of these inhibitors lack high selectivity. 
When recorded from in vitro most spinally-projecting 
SPANs fire action potentials spontaneously [41, 54], but they 
are apparently quiescent in vivo [55-58]. This implies that 
the tonic inhibition of spinally-projecting SPANs may be, in 
part at least, lost in the preparation of brain-slices for in vitro
recording. 
3. NEUROTRANSMITTERS RELEASED BY SPANS 
  Discussion of the neuropharmacology of SPANs can in-
clude neurotransmitters released by the neurones and neuro-
transmitters acting upon them. The first of these questions 
has been approached by the use of retrograde/anterograde 
labelling, trans-synaptic tracing, immunohistochemistry and 
in situ hybridisation. Using these techniques it has been 
demonstrated that spinally-projecting SPANs express met-
endorphin (20%), dynorphin (up to 40%), oxytocin (up to 
40%) and vasopressin (up to 40%) [59-61]. However, a sig-
nificant proportion also produce dopamine, met-enkephalin 
(10%), leu-enkephanlin, somatostatin, angiotensin II and 
atrial natriuretic peptide [62-65]. This clearly implies that 
some SPANs express more than one neuropeptide neuro-
transmitter. Interesting questions which remain unanswered 
include: what combinations of neurotransmitters are ex-
pressed by particular neurones, and, do different neurotrans-
mitters serve different functions? For example, the closely 
related neuropeptides oxytocin and vasopressin are com-
monly co-expressed [see for example 66].  
  The anatomical evidence that vasopressin acts a SPAN 
neurotransmitter is supported by functional experiments in 
which PVN neurones were stimulated, producing an imme-
diate increase in renal sympathetic nerve activity (rSNA) and 
mean arterial blood pressure [67]. However, these effects 
were prevented by lower thoracic intrathecal preloading with 
the vasopressin 1a (V1a)-receptor antagonist d(CH2)5 [Tyr(me)
2,
arg
8]vasopressin [67]. Interestingly, since oxytocin exerts 
effects both through the oxytocin receptor (OT-R) and 
through the V1a–R [68], some of the effects attributed to   
oxytocin may in fact be mediated by the latter. However, 
oxytocin is clearly important as a neurotransmitter of 
SPANs, since both vasopressin and oxytocin levels increase 
in the spinal cord when the PVN is stimulated [69].   
Additionally, the tachycardia associated with PVN stimula-
tion is reduced by the highly selective OT-R antagonists 
d(CH2)5[Tyr(Me)
2, Orn
8]-oxytocin and L-368,899 [70]. One 
explanation suggested for the apparent disparity of the ef-
fects of oxytocin and vasopressin antagonists is that SPAN 
neurotransmission in the upper thoracic spinal cord is medi-
ated via oxytocin, but in the lower thoracic cord it is medi-
ated by vasopressin [30].  
  Dopamine has also been strongly implicated as a SPAN 
neurotransmitter [65], but its activity is complex. Several 
reports demonstrate that dopamine, and its mimetic apomor-
phine, excite sympathetic pre-ganglionic neurones in rats (ie. 
the neurones that SPANs would act upon) [71-74]. However, 
evidence also suggests that it may serve as an inhibitor of 
sympathetic activity [75]. Data supporting the function of the 
other putative SPAN neurotransmitters described above is, 
so far, more disparate. For example, intrathecal glutamate 
antagonists reduce the increases in rSNA seen following 
chemical stimulation of the PVN [75] suggesting that the 
excitatory amino acid glutamate may act as a SPAN output 
neurotransmitter. However, whilst enkephalins and angio-
Fig. (3). Actions of spinally-projecting SPANs originating in the 
paraventricular nucleus (PVN) of the hypothalamus. The PVN 
lies alongside the 3
rd ventricle (3v), and contains a number of neu-
rones which project to the intermediolateralis (IML) of the spinal 
cord. When stimulated with excitatory neurotransmitters or electri-
cal current, they activate sympathetic pre-ganglionic neurones in 
the IML which, in turn, increase heart rate and blood pressure and 
glucose secretion. They may also increase TSH release. These PVN 
neurones are tonically inhibited by GABA input. Please see main 
text for references. 
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tensin II are both produced by SPANs [59, 60, 62-64] and 
modulate sympathetic pre-ganglionic neurones [76-78] in 
rats, pharmacological block of their respective receptors (at 
the level of the spinal cord) has not been shown directly to 
prevent the sympathetic effects of PVN stimulation. This 
may be because SPANs expressing these neurotransmitters 
innervate pre-ganglionic neurones targeting less well charac-
terised sympathetic effectors in the viscera [79] or simply 
that appropriate experiments to detect such effects have yet 
to be conducted. The amino acid -aminobutyric acid 
(GABA) is the most abundant inhibitory neurotransmitter in 
the central nervous system [80]. Recent analysis of both ret-
rograde and trans-neuronal labelling data shows that whilst 
spinally-projecting SPANs receive GABA-ergic synapses, 
they do not contain GABA themselves [81].  
  In addition to the pathways leading from the PVN to the 
IML thence to the heart and blood vessels there are pathways 
projecting from the superchiasmatic nucleus (SCN), to the 
thyroid and to the liver, via the PVN [82-84]. Many neurones 
in this pathway express thyroid stimulating hormone   
(TSH) [82], possibly in the PVN spinally-projecting SPANs 
themselves. 
4. NEUROTRANSMITTERS ACTING ON SPANS 
  Far more studies have been published looking at the neu-
rotransmitters expressed by SPANs than looking at neuro-
transmitters acting on SPANs. This is disappointing since, 
arguably, knowledge of the receptors expressed by a cell 
gives greater therapeutic potential than knowledge of the 
transmitters released by it. A useful approach has been the 
combination of retrograde labelling and patch-clamp record-
ing. In these studies, tracer is injected into the IML of the 
spinal cord, and a few days later brain slices are prepared. 
Spinally-projecting neurones are then clearly visible and can 
be targeted for electrophysiological study (Fig. 4). 
4.1. Amino Acid Neurotransmitters 
  A number of in vivo studies have investigated the neuro-
transmitters acting upon SPANs, or the receptors expressed 
by them, but there have been few in vitro studies on identi-
fied spinally-projecting SPANs. In vivo electrophysiological 
studies on cats confirmed an anticipated monosynaptic con-
nection between the PVN and the spinal sympathetic motor 
area (the IML) [85]. Furthermore, electrical or chemical 
stimulation of the PVN was shown to generate a rapid rise  
of blood pressure and rSNA in conscious rats [86]. Further  
in vivo studies showed that PVN neurones receive tonic 
GABA-ergic inhibition, which maintains their spontaneous 
action potential discharge at relatively low rates [55, 57, 58, 
87], despite additional excitatory glutaminergic input [86].  
  There is accumulating evidence that “tonic” inhibition is 
often mediated by GABA arising from extra-synaptic 
sources; sometimes referred to as “volume” GABA neuro-
transmission [88-89]. This correlates with the expression of 
 5-, or  6-type, and  -type GABAA receptor subunits [90, 
91]. However, this has not yet been specifically examined 
with spinally-projecting SPANs. It may be an important is-
sue to explore though, since a unique pharmacological pro-
Fig. (4). Methods for patch-clamping retrogradely-labelled neurones. A, the retrograde tracer fluorogold is injected into the rat interme-
diolateralis (IML) at level T2-T4, it is also possible to use other tracers, such as rhodamine-labelled microspheres (see Fig. 8). The IML is 
dense with pre-ganglionic neurones that project to the superiocervical (SCG) and stellate (SG) ganglia, and from there to the heart and blood 
vessels [65, 227]. The appearance of a fluorogold-labelled neurone B, prior to patch clamp recording, C, during patch-clamp, under near 
infrared differential interference contrast microscopy, and D, when patched with Lucifer yellow (a fluorescent dye) in the patch clamp  
pipette. The dye fills the neurone, and this gives re-confirmation that recording was from the appropriate cell. Reproduced from [43], with 
permission. 
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file for extra-synaptic GABA receptors is emerging, [91-93] 
which may become therapeutically exploitable.  
  In the case of SPANs, loss of tonic inhibition would lead 
to an increase in sympathetic outflow. Excessive sympathetic 
outflow could potentially be reduced by selective activators 
of “volume” GABA receptors. Furthermore, the degree of 
tonic inhibition of sympathetic outflow is, in part at least, 
dependent upon the local uptake of GABA by transporter 
proteins, in particular GAT3 located on glial cells [94]. 
Therefore, there are a number of means by which parvocellu-
lar GABA inhibition could be targeted with the aim of reduc-
ing sympathetic outflow and blood pressure.  
  Excitation of the PVN by either glutamate or the GABAA
receptor antagonist bicuculline increases blood pressure and 
heart rate, due to the tonic silence of SPANs [55, 56, 86, 87, 
95]. This has led to many in vitro studies investigating con-
trol of SPANs to focus on the role of GABA. In fact, a num-
ber of studies have demonstrated the presence of GABAA
receptor currents in the PVN [38, 87, 96-100]. The parvocel-
lular region of the PVN, which contains the majority of 
SPANs, expresses a high density of GABAA  2 –subunits 
[101]; this was also seen in retrogradely labelled spinally-
projecting SPANs [102]. Additional studies have shown spi-
nally-projecting parvocellular neurones to be inhibited by 
GABA [31, 54, 103-104], as predicted by the earlier in vivo
work. Interpretation of both the in vivo and in vitro work is 
further complicated by some frequently overlooked vari-
ables. Firstly, there is little consideration of the role of pre-
synaptic GABA receptors. These are typically of the GABAB
receptor subtype and have been shown to inhibit both inhibi-
tory and excitatory input to spinally-projecting SPANs [105]. 
Secondly, the primary GABAA antagonist used to investigate 
possible GABA involvement is bicuculline or bicuculline 
methiodide, both of which are potassium channel blockers 
[106-108]. The effect of potassium channel inhibition would 
appear very similar to block of GABAA receptors; excitation.  
  Neuroactive steroids and nitric oxide (NO) are well 
known modulators of GABAA receptors. In the PVN, for 
example, tetrahydrodeoxycorticosterone (THDOC) [103] 
modulates spinally-projecting SPANs and NO modulates 
rostral ventrolateral medulla (RVLM)-projecting SPANs 
[109]. Both effects are mediated by modulation of GABAA
receptors [110]. However, other steroid hormone receptors, 
such as oestrogen -receptors [111], are expressed by 
SPANs, which raises the possibility that some steroids may 
modulate sympathetic outflow by this mechanism. Other 
mechanisms may also be involved, for example cortisol is 
known to activate SPANs at high doses via an inhibition of 
potassium channels [100]. 
  SPANs are excited by the excitatory amino acid neuro-
transmitter glutamate [31], mediated by the activation of at 
least two fast ionotropic glutamate conductances. This is 
carried largely by  -amino-3-hydroxy-5-methyl-4-isoxazole- 
propionic acid (AMPA) receptors (i.e., sensitive to 2,3-
dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione, 
NBQX, an AMPA receptor antagonist), but with an addi-
tional component of N-methyl D-aspartate (NMDA) conduc-
tance (i.e., sensitive to the classical NMDA antagonist   
amino-5-phosphonovaleric acid, AP-5, [31]).  
  Combined electrophysiological and microdialysis studies 
on RVLM-projecting PVN neurones have shown that at least 
some of their glutaminergic input is also tonically inhibited 
by GABAA-receptors. Since glutaminergic neurotransmis-
sion is ubiquitous within the central nervous system, there 
has been particular recent focus on non-glutaminergic excita-
tion of SPANs. This is because antagonism of the relatively 
sparse neuropeptide receptors could become therapeutically 
useful when action of amino acid receptor antagonists proves 
to be too widespread.  
4.2. Neuropeptide Neurotransmitters 
  Leptin [112], angiotensin II (AGII) [113, 114], neuropep-
tide W [115] and each of the endogenous tachykinins [54] 
have all been investigated as pharmacological regulators of 
spinally-projecting SPANs. The strongest candidates appear 
to be AGII and the tachykinin substance P (SP), with both 
neuropeptides acting indirectly via GABA neurotransmission 
[54, 114].  
4.2.1. Angiotensin II 
  The neuropeptide AGII, expressed by PVN neurones 
[116], acts at two principal receptors: AT1 and AT2. AT1 is 
the more abundant of the two [117-118] and, in rodents, is 
encoded by two genes: AT1A and AT1B [119]. However, it is 
not clear whether both of these subtypes exist in humans, nor 
which subtype is more important for cardiovascular control 
in rodents. It has been suggested that AT1B is more important 
for control of blood pressure in mice [120], but in situ hy-
bridisation studies show that AT1A is expressed more richly 
in the parvocellular region of the rat PVN [121], the region 
particularly important for autonomic control. Integrative 
experiments showed that AGII injection into the PVN gave 
an AT1-dependent increase in blood pressure [122], and sin-
gle-unit recording studies of antidromically-identified neu-
rones demonstrated that this involved spinally-projecting 
SPANs [123]. Later, the same group demonstrated inhibition 
of A-type potassium currents by AGII, acting via  an AT1
receptor [124]. Whilst AGII directly modulates medulla-
projecting PVN neurones [125] to elevate blood pressure, 
spinally-projecting SPANs do not express AT1 receptors 
[113]. Therefore, this implies that AGII activates SPANs 
indirectly, and this was investigated using whole-cell record-
ing from retrogradely labelled spinally-projecting SPANs 
[114]. In these experiments, AT1 receptors were found to co-
localise with synaptophysin (a pre-synaptic marker protein). 
In addition, AGII decreased the frequency and amplitude of 
spontaneous inhibitory post-synaptic potentials in SPANs. 
This strongly suggests that AGII excites spinally-projecting 
SPANs by reducing the tonic GABA-ergic input.  
4.2.2. Tachykinins 
  The tachykinin family of neuropeptides, which includes 
substance P (SP), neurokinin A (NKA) and neurokinin B 
(NKB), is involved in central cardiovascular control [126]. 
Studies have shown high levels of tachykinin receptor ex-
pression within the PVN [127-129] and in our own studies 
we showed that injection of SP into the PVN increases heart 
rate, blood pressure (Fig. 6) and rSNA [54]. These effects 
correlated with our observation of a strong inhibition of 
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by SP in brain slice experiments was only apparent when 
neurones were first inhibited by GABA (Fig. 5).  
  All three of the principal mammalian tachykinin recep-
tors (NK1, NK2 and NK3) are 7-transmembrane G-protein 
coupled receptors, although they act through a range of in-
tracellular pathways, typically via pertussis toxin independ-
ent G-proteins [130, 131]. Of particular interest is that NK1 
receptors activate protein kinase C (PKC) [131], and that 
PKC-dependent phosphorylation of GABAA can inhibit 
GABAA currents [132]. This was first shown using cultured 
cells expressing recombinant GABAA subunits. However, 
SPAN activation by SP in the PVN was also found to be 
both PKC and NK1 receptor dependent (Figs. 5 and 7) [54]. 
No effects of NKA or NKB agonists were observed (NKA4-
10 and senktide, respectively). An interesting question re-
mains; from where do the tachykinin inputs to SPANs arise? 
Of note, several intra-hypothalamic tachykinin pathways 
terminate in the PVN [133]. Furthermore, in brain slice   
experiments we found that SPAN activation following glu-
tamate stimulation of the DMH was inhibited by tachykinin 
receptor antagonists [134]. This may prove significant since 
there is evidence that both the DMH and the PVN are impor-
tant in the control of the cardiovascular system [135]. 
4.2.3. Vasoctive Intestinal Peptide (VIP) and Pituitary 
Adenylcyclase Activating Peptide (PACAP)  
  Retrograde labelling evidence has demonstrated the pres-
ence of vasoctive intestinal peptide/pituitary adenylcyclase 
activating peptide receptors type 2 (VPAC2) on spinally-
projecting SPANs [136]. PACAP(1 to 38) induced c-fos expres-
sion in PVN spinally-projecting neurones and this was abol-
ished by a VPAC2 receptor antagonist [136]. It seems likely, 
from functional and viral tracing studies that these neurones 
are also activated by thyroid hormone (T3) [137], although 
receptors have not yet been identified specifically on the 
Fig. (5). Substance P (SP) increases the rate of action potential discharge of individual neurones in brain slices in the presence of 
GABA. Brain slices were taken from adult rats, and action potentials recorded from single neurones in the PVN. A, representative results 
showing SP applied to SPANs under control conditions; B, mean results, showing SP alone has no effect on rate of action potential dis-
charge. C, representative results showing application of GABA; D, mean results showing that GABA inhibits spontaneous action potential 
frequency. E, representative results showing SP added during GABA inhibition; F, mean results showing that SP increases the rate of action 
potential discharge against a background of tonic GABA inhibition. G, Representative results showing SP interaction with NK1 antagonism; 
H, mean results showing the effects of SP are abolished by the selective NK1 antagonist L703606. Cont = control. Reproduced from [54], 
with permission. 
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PVN spinally-projecting SPANs. Both the VPAC2 receptors 
and T3 nuclear receptors (TR) appear to be involved with 
control of endogenous glucose production by the liver, see 
below for further discussion [136, 137]. 
4.3. Other Receptors on Spinally-Projecting SPANs  
  Purinergic receptors were originally classed as either P1 
or P2 subtypes [138]. The P1 receptors are now termed 
adenosine receptors, Ax and are seven transmembrane G-
protein couple receptors [139]. The P2 receptors are the 
ligand-gate cation channels activated by nucleotides [139]. 
Examples of both families of receptors have now been iden-
tified on PVN SPANs [45, 140], but only P1 on identified 
spinally-projecting SPANs [45]. Adenosine is inhibitory to 
several types of muscle cell, by acting via A1 receptors and 
KATP channels [141-143]. Li et al. [45] has now established 
that adenosine acts on spinally-projecting SPANs in a similar 
manner. P2X receptors have been identified on RLVM-
projecting SPANs [140], but it remains to be seen if these 
receptors are also expressed on spinally-projecting SPANs. 
There are little data supporting the presence of other recep-
tors on spinally-projecting SPANs. Price et al. [115] used 
multiplex single-cell RT-PCR experiments in combination 
with whole-cell recording in brain slices to show inhibition 
of SPAN neurones by neuropeptide W. This study did not 
use retrograde labelling to identify SPANs, but rather elec-
trophysiological “finger-printing” and post-hoc identification 
of neuronal expression of vasopressin or oxytocin. Neu-
ropeptide W is thought of as being a regulator of feeding 
behaviour (see for example [144]) and in this case was found 
to be acting through the neuropeptide W type 1 (NPBW1) 
receptor.  
  Receptors for neuropeptide FF are densely expressed in 
the PVN and excite both magnocellular [145] and parvocel-
lular [146] PVN neurones. These include neurones that pro-
ject to the nucleus of the solitary tract [147], but there has 
been no investigation of their effects specifically on spinally-
projecting SPANs. Evidence also suggests that leptin [148-
150] may influence SPANs of the PVN. The leptin receptor 
(OB-R) is highly expressed in the PVN [151], and PVN neu-
rones are depolarised by leptin [152]. However, leptin does 
not increase c-fos expression in spinally-projecting SPANs 
[112], suggesting that the PVN neurones being activated   
by leptin are not SPANs. Indeed, our own immunohisto- 
chemical data show that OB-R is expressed by neurones   
Fig. (6). Substance P (SP) injected into the PVN elicits a rise in heart rate and blood pressure. Heart rate and blood pressure were re-
corded in anaesthetised adult rats. Representative records of A, heart rate and B, blood pressure during intra-PVN injection of SP/FITC-SP 
(solution of SP and FITC-conjugated SP). C, mean data from a number of experiments. D, epifluorescent image of the medial PVN, after 
SP/FITC-SP intra-PVN injection. “3V” indicates the third ventricle; the white arrow indicates a parvocellular neurone labelled with FITC-
SP. Scale bar is 50m. “SP” indicates SP/FITC-SP injection. Reproduced from [54], with permission. 
Fig. (7). Pharmacological control of SPANs within the PVN. 
Spinally-projecting SPANs are tonically inhibited by GABA input, 
which is normally enhanced by nitric oxide (NO). However, during 
chronic heart failure, this potentiation of GABA is lost, leading to 
an overall increase in sympathetic activity. Substance P (SP) causes 
indirect activation of spinally-projecting SPANs by inhibition of the 
inhibitory GABAA receptors, via  a protein kinase C (PKC)-
dependent pathway. 
GABAA(2) receptor
Chronic
heart
failure
NO
PKC
SP
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immediately surrounding SPANs (unpublished data, (Fig. 8)), 
but not by the spinally-projecting SPANs themselves. Orexin 
has also been shown to depolarise neurones within the PVN, 
but again, this has not been shown specifically with SPANs 
[153]. It has been suggested that other neurotransmitters   
such as adrenomedullin [154] may also activate spinally-
projecting SPANs, however, this has not yet been shown 
directly.  
Fig. (8). Spinally-projecting SPANs do not co-localise with 
leptin receptor (OB-R) in rat PVN. Spinally-projecting SPANs 
were labelled with rhodamine beads (red) using retrograde labelling 
(see Fig. 2) in an adult rat. A 40m cryo-slice of the PVN was 
counter-stained for OB-R (green), using primary goat anti-OB-R 
IgG, Santa Cruz biotechnology; secondary rabbit anti-goat, Jack-
son. Scale bar is 10m. Unpublished data.
5. PHYSIOLOGICAL IMPLICATIONS OF SPAN   
ACTIVITY 
  Spinally-projecting SPANs of the PVN influence the 
cardiovascular system [7, 155] (Fig. 3), and there is clear 
evidence that the functioning of these neurones is altered 
during heart failure [15, 35]. However, the role of these   
neurones in normal physiology remains controversial. There 
is evidence PVN SPANs are involved in physiological   
functions as diverse as stress, thermoregulation and penile 
erection.  
5.1. Involvement with Stress Response 
  In addition to the clear increases in blood pressure ob-
served with physical activity [156], the simple act of antici-
pating exercise [157] or performing mental arithmetic [158-
159] is sufficient to produce a cardiovascular response. In 
excess, this preparatory reflex leads to increases in heart rate 
and blood pressure of a pathological nature [160-162]. Duan 
et al. showed that the stress “phenotype” could be repro-
duced by stimulation of the PVN [163] and non-specific 
chemical inhibition of the PVN prevents it [164]. Certainly, 
the PVN is central to the integration of the hormonal re-
sponse to stress [5] and it also well known that stimulation of 
SPANs in the PVN exerts a powerful influence on blood 
pressure and heart rate and sympathetic nerve activity [55-
57, 86, 95, 165-167].  
 In  vivo experiments suggest that tachykinins play a major 
role in cardiovascular control and the expression of a cardio-
vascular stress response [126]. For example, SP is found at 
high levels within the PVN [168], and central tachykinins 
increase efferent sympathetic nerve activity [54, 169]. Fur-
thermore, injection of tachykinin agonists into the hypo-
thalamus [126, 170], and specifically the PVN [54, 171, 
172], leads to rapid elevation of heart rate and blood pressure 
(Fig. 6). Crucially, central administration of tachykinin an-
tagonists reduces the elevation of blood pressure and heart 
rate resulting from psychological stress of conscious rats 
[173]. Trans-synaptic retrograde labelling experiments show 
a direct coupling between the stellate ganglion (which sup-
plies sympathetic motor neurones to the heart) and the PVN 
[32], implicating PVN SPANs in control of the stress re-
sponse. In fact PVN SPANs were included in the set of “cen-
tral command neurones” identified by Jansen et al. [32], and 
inferred from the work of Walter B. Cannon in the early 
1900s [174].  
  However, some scientists now reject this idea; several 
lines of evidence suggest that whilst the PVN is activated by 
stress, and stimulation of the PVN elicits increases in blood 
pressure and heart rate, it is the DMH which is important for 
the cardiovascular response to stress [135]. This conjecture is 
based on the observation that injection of the GABAA an-
tagonist bicuculline into the DMH prevents the cardiovascu-
lar response to air-jet stress, whereas injection into the PVN 
does not [175]. Whether this PVN SPAN-independent car-
diovascular response to stress is general, or stress paradigm-
specific, remains to be seen. Furthermore, since the activa-
tion of SPANs by SP involves the relief of GABAA inhibi-
tion [54], inhibition of the PVN by GABA may not be the 
ideal means of testing this hypothesis. Non-specific PVN 
lesion experiments such as Busnardo and colleagues’ recent 
work [164], or specific block of spinally-projecting SPAN 
neurotransmitter receptors may resolve the controversy. 
5.2. Control of Blood Volume 
  It has been suggested that spinally-projecting PVN neu-
rones may be involved in the response to changes in blood 
volume [24, 176, 177]. This can, to a certain extent, be dif-
ferentially regulated from blood pressure, by the cardiovas-
cular system. The atrial/venous side of the cardiovascular 
system is relatively compliant and “expands” to accommo-
date increased blood volume with relatively little change in 
pressure; small decreases in volume are replenished from 
capacitance vessels [178]. Activation of veno-atrial stretch 
receptors by inflation of small balloons activates afferents 
and results in a reflex tachycardia (equivalent to the Bain-
bridge reflex) [179]. Similar results can be obtained by mod-
est changes in blood volume, which alters veno-atrial stretch 
receptor activity without substantially changing blood pres-
sure. For example, removal of 2mls of blood from adult rats 
(~10% blood volume, by arterial cannula) has no effect on 
mean blood pressure, but does increase c-fos expression in 
PVN spinally-projecting SPANs [180]. Similar results are 
seen in the rat water deprivation model of Toney and col-
leagues [181] and cardiovascular responses to water depriva-
tion are reduced by GABA inhibition of the PVN [182]. 
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spinally-projecting SPANs are involved with the control of 
blood volume.  
5.3. Circadian Rhythm 
  Human blood pressure typically follows a distinct cir-
cadian rhythm, dipping overnight and rising in the morning 
[183]. It is notable that this rise occurs before waking up 
[184]. In some cases, hypertension is characterised by not 
just elevated blood pressure, but by a disturbed circadian 
pattern of blood pressure. Specifically, the usual night time 
blood pressure decrease fails to occur [185, 186]. This dis-
turbance to the normal circadian cardiovascular pattern may 
contribute to the statistically higher number of cardiovascu-
lar deaths occurring first thing in the morning [187, 188]. 
Circadian rhythm is largely controlled at the level of the hy-
pothalamus and, in particular, the suprachiasmatic nucleus 
(SCN) [189], which expresses a number of clock gene prod-
ucts [190, 191]. There are strong excitatory and inhibitory 
pathways from the SCN to the PVN of rats [99, 192], and, 
specifically, to spinally-projecting SPANs [31]. It is there-
fore possible that spinally-projecting SPANs play a role in 
circadian control of blood pressure. 
5.4. Penile Erection  
  The PVN is involved with penile erection in rats [193]. 
Oxytocinergic PVN neurones, which have a positive effect 
on penile erection, project to the hippocampus, the medulla 
and, most importantly, the spinal cord (For reviews see [194, 
195, 196]). A retrograde tracing study using pseudorabies 
virus has shown central nervous system (CNS) innervations 
of the penis to include sympathetic pre-ganglionic neurones 
and the PVN, specifically parvocellular neurones in the PVN 
[197]. From here, it appears likely that continuation of the 
sympathetic pathway involves serotonin and/or dopaminer-
gic neurotransmission in the lower spinal cord [198, 199]. 
5.5. Glucose Control  
  Glucose-sensing by the brain requires input from a num-
ber of sensors, including the liver, carotid body and small 
intestine, as well as glucose-sensitive neurones in the brain 
[reviewed by 200]. Direct stimulation of the PVN by mi-
croinjection of glucose into the PVN causes an increase in 
sympathetic stimulation to brown adipose tissue (BAT) 
[201]. More indirect stimulation by peripheral glucose injec-
tion also activates the PVN, as shown by increased c-fos
expression, particularly in identified SPANs [202, 203]. In 
brain slice experiments, SPANs are modulated by hypogly-
caemia [44], but the mechanisms of this still need to be de-
termined. Blood glucose levels are heavily regulated by the 
liver, which is under a degree of control by the autonomic 
nervous system. This includes sympathetic innervations pro-
jecting from the PVN [82, 84, 136, 204], which have been 
shown to alter blood glucose levels by influencing the liver 
[83, 137].  
5.6. Regulation of Body Fat 
  Two papers have shown that PVN neurones project to 
brown adipose tissue (BAT) via spinally-projecting sympa-
thetic nerves [205, 206]. In both cases, pseudorabies virus 
was injected into interscapular brown adipose tissue and, 
after a number of days, immunostaining for the virus could 
be found in the IML and the PVN. Although this demon-
strates a connection from the PVN to BAT, the mechanism 
remains unclear. Pharmacological stimulation of the PVN by 
microinjection of stimulatory amino acids has been shown to 
produce differing effects. Amir [207] showed an increase in 
sympathetic outflow to BAT, Yoshimatsu and colleagues 
[208] found small decreases in sympathetic activity when the 
anorexigenic peptide cholecystokinin (CCK) was injected 
into the PVN, but showed a mainly a stimulatory response to 
injected glutamate [209]. Conversely, Madden and Morrison 
[210] showed an inhibitory effect. Obviously there is a   
potential involvement of SPANs with regulation of body   
fat, but the details remain unclear. 
5.7. Thermoregulation 
  Thermosensitivity of neurones in the PVN was first 
shown by Inenaga et al. [211]. Poly-synaptic viral tracing 
studies in rats show that PVN SPANs are directly involved 
in thermoregulation [212]. Since then the region has been 
shown to be critical in thermoregulation [213-214]. Projec-
tions from the PVN to the RVLM, which contains sympa-
thetic pre-motor neurones, are activated following heat expo-
sure [215]. In addition, heat exposure activates spinally-
projecting PVN neurones [216]. Whether this involves a 
simple vasomotor responses to elevated temperature (e.g., 
sympathetic vasodilation of skin in humans [217] or tail in 
the case of rodents [212]) or some other process is unknown. 
The PVN also has an effect on thermogenesis, via innerva-
tions of brown adipose tissue (see above). 
5.8. Involvement with Heart Failure 
  Whilst chronic heart failure could not be described as a 
function of SPANs, the relationship between NO, GABA 
and SPAN activity is fundamental to the development of 
elevated sympathetic activity seen in human patients and 
animal models of heart failure [15, 33-34, 218]. NO is now 
well established as a neuromediator in the CNS where it is 
synthesised by neuronal nitric oxide synthase (nNOS) 
[reviewed by 219, 220]. nNOS is abundantly and constitu-
tively expressed throughout the brain, but particularly in 
cells of the PVN; this includes expression by pre-autonomic 
neurones projecting both to the IML [221] and the RVLM 
[222, 223]. NO appears to increase the tonic inhibition of 
SPANs [224] by facilitating pre-synaptic release of GABA 
[223]. In models where chronic heart failure has been ex-
perimentally induced in rats, there are decreased levels of 
nNOS expression in the PVN [225], together with evidence 
of reduced neuronal activity [218]. Furthermore, the degree 
of tonic inhibition of rSNA by GABA (albeit assessed with 
bicuculline) was reduced in the chronic heart failure animals 
[35]. When combined these data strongly suggest that the 
tonic inhibition of sympathetic activity is maintained by an 
NO-dependent local release of GABA, and that chronic heart 
failure leads to a loss of NO activity, and thus to a loss of 
inhibitory control of sympathetic neurones [36] (Fig. 7). It 
has recently been shown that AT1 receptor mRNA expres-
sion is increased in the PVN and, consequently, intra-PVN 
injection of AGII is more effective at increasing rSNA in the 
rat chronic heart failure model [226]. Further experiments 
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activity is causal, coincident or consequent to the decreased 
nNOS expression in the PVN. 
6. CONCLUSIONS 
  Several studies have investigated the function and phar-
macology of spinally-projecting SPANs in the PVN but, 
interestingly, we still know a great deal more about the ex-
pression of their neurotransmitters than anything else. There 
is relatively sparse information concerning which receptors 
are expressed by SPANs; GABAA, glutamate, adenosine A1
and NK1 receptors are all strong candidates, and SPANs can 
be indirectly modulated by NO and AGII. In terms of the 
modulation of SPANs, tonic inhibition is a recurrent theme 
and clearly central to their regulation. For example, NO, 
AGII and SP all appear to act by modulating this GABA 
tone. These neurones modulate the cardiovascular system, 
and it seems likely that they have other functions too. So a 
big question seems to be: what is the primary role of these 
neurones in cardiovascular function? There is evidence they 
become involved in the pathological increase in sympathetic 
activity associated with chronic heart failure, but this still 
leaves the function in normal, healthy animals unknown. 
Putative physiological functions include: volume regulation, 
glucose control, circadian rhythm and response to stress. 
Perhaps PVN SPANs play a role in all of these. The final 
question would then be, do the same neurones play a role in 
each of these functions, or does a mixed population of 
SPANs exist, each with a different receptor and neurotrans-
mitter profile and each with a separate function? A great 
many further experiments will be required to finally answer 
these fascinating questions. 
ABBREVIATIONS 
3V =  3
rd ventricle 
AGII =  Angiotensin  II 
AMPA =   -amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid 
AP-5 =  Amino-5-phosphonovaleric  acid 
AT1  =  Angiotensin II type 1 receptor 
AT2  =  Angiotensin II type 2 receptor 
BAT =  Brown  adipose  tissue 
CCK =  Cholecystokinin 
CNS =  Central  nervous  system 
CVS =  Cardiovascular  system 
DMH =  Dorsomedial  hypothalamus 
FITC =  Fluorescein  isothiocyanate 
GABA =  -aminobutyric acid 
HPA =  Hypothalamic-pituitary-adrenal 
IML =  Intermediolateralis 
NBQX =  2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione 
NKA =  Neurokinin  A 
NKB =  Neurokinin  B 
NMDA =  N-methyl  D-aspartate 
nNOS  =  Neuronal nitric oxide synthase 
NO =  Nitric  oxide 
NTS  =  Nucleus of the solitary tract 
OB-R =  Leptin  receptor 
OT-R =  Oxytocin  receptor 
PACAP  =  Pituitary adenylcyclase activating peptide 
PKC  =  Protein kinase C 
rSNA  =  Renal sympathetic nerve activity 
RT-PCR  =  Reverse transcriptase PCR 
RVLM  =  Rostral ventrolateral medulla 
SCG =  Superiocervical  ganglion 
SCN =  Suprachiasmatic  nucleus 
SG =  Stellate  ganglion 
SP =  Substance  P 
SPAN  =  Sympathetic pre-autonomic neurone 
T3 =  Thyroid  hormone 
THDOC =  Tetrahydrodeoxycorticosterone 
TSH  =  Thyroid stimulating hormone 
TR  =  Thyroid hormone receptor 
V1a-receptor  =  Vasopressin 1a receptor 
VIP =  Vasoctive  intestinal  peptide 
VPAC2  = Vasoctive intestinal peptide/pituitary 
adenylcyclase activating peptide recep-
tors type 2 
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